BAM
CELG

Brave Asset Management’s Celgene Corp CELG Stock Holding History

Brave Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,195
Closed -$1.25M – 176
2019
Q1 		$1.25M Sell
13,195
-8,470
-39% -$741K 0.69% 40
2018
Q4 		$1.39M Buy
21,665
+3,610
+20% +$266K 0.93% 33
2018
Q3 		$1.62M Buy
18,055
+100
+0.6% +$8.84K 0.83% 37
2018
Q2 		$1.43M Sell
17,955
-22,178
-55% -$1.84M 0.83% 44
2018
Q1 		$3.58M Buy
40,133
+717
+2% +$68.8K 2.16% 8
2017
Q4 		$4.11M Sell
39,416
-882
-2% -$99.5K 2.14% 8
2017
Q3 		$5.88M Sell
40,298
-2,954
-7% -$402K 3.08% 6
2017
Q2 		$5.66M Buy
43,252
+187
+0.4% +$22.9K 3.01% 6
2017
Q1 		$5.36M Sell
43,065
-1,009
-2% -$121K 3.13% 6
2016
Q4 		$5.1M Buy
44,074
+1,333
+3% +$148K 3.26% 4
2016
Q3 		$4.47M Sell
42,741
-1,177
-3% -$127K 2.86% 4
2016
Q2 		$4.33M Buy
43,918
+1,468
+3% +$152K 2.9% 4
2016
Q1 		$4.25M Buy
42,450
+530
+1% +$54.6K 2.99% 3
2015
Q4 		$5.02M Sell
41,920
-77
-0.2% -$8.91K 3.39% 3
2015
Q3 		$4.54M Buy
41,997
+11,875
+39% +$1.47M 3.47% 2
2015
Q2 		$3.49M Buy
30,122
+470
+2% +$53.7K 2.44% 3
2015
Q1 		$3.42M Hold
29,652
– – 2.4% 3
2014
Q4 		$3.32M Sell
29,652
-600
-2% -$63.3K 2.38% 3
2014
Q3 		$2.87M Buy
30,252
+15,226
+101% +$1.37M 2.13% 6
2014
Q2 		$1.29M Sell
15,026
-15,026
-50% -$1.14M 0.91% 33
2014
Q1 		$2.1M Buy
30,052
+100
+0.3% +$7.92K 1.66% 11
2013
Q4 		$2.53M Buy
+29,952
New +$2.37M 2.02% 8

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Brave Asset Management's CELG Position: Q2 2019 in Review

Brave Asset Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 13,195 shares — an estimated $1.25M sold.

Brave Asset Management first reported a position in CELG in Q4 2013 and held it in 22 quarters. The position peaked at $5.88M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Brave Asset Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Brave Asset Management sold 13,195 Celgene Corp shares in Q2 2019, an estimated $1.25M.
  • Brave Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 22 quarters.
  • Brave Asset Management's Celgene Corp position peaked at $5.88M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Brave Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.